Cullinan Therapeutics, Inc. CGEM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s total current liabilities?
- Cullinan Therapeutics, Inc. (CGEM) reported total current liabilities of $35.15M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Cullinan Therapeutics, Inc.'s total current liabilities increased by 28.5% year-over-year, from $27.35M to $35.15M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total current liabilities has grown at a 21.4% compound annual growth rate (CAGR), from $14.32M to $37.74M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.